Glenn Baity is VP at ACADIA PHARMACEUTICALS INC (ACAD). They have made 1 open-market trade across 1 company since 2012, most recently 2018-01-29.
CIK 0001487100
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACAD | 83,734 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2018-01-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACAD | SELL · 10b5-1 | 2018-01-29 | 2018-01-31 | $32.39 | $1.2M | -2.5% | -20.0% | -44.3% |
| ACAD | SELL · 10b5-1 | 2018-01-02 | 2018-01-04 | $30.14 | $2.2M | -2.2% | -6.8% | -22.6% |
| ACAD | SELL | 2017-10-05 | 2017-10-06 | $40.91 | $3.1M | -4.7% | -15.5% | -25.3% |
| ACAD | SELL · 10b5-1 | 2017-08-30 | 2017-09-01 | $34.87 | $924K | +1.0% | +6.8% | -16.0% |
| ACAD | SELL · 10b5-1 | 2017-08-09 | 2017-08-11 | $34.88 | $500K | +1.3% | +17.7% | -7.4% |
| ACAD | SELL · 10b5-1 | 2017-07-20 | 2017-07-21 | $30.00 | $1.1M | -3.0% | +1.7% | +17.8% |
| ACAD | SELL · 10b5-1 | 2017-06-22 | 2017-06-26 | $30.00 | $57K | +0.6% | +3.8% | +29.8% |
| ACAD | SELL · 10b5-1 | 2017-02-14 | 2017-02-16 | $39.66 | $1.0M | -6.1% | -4.7% | -30.7% |
| ACAD | SELL · 10b5-1 | 2017-02-01 | 2017-02-03 | $35.15 | $1.1M | +8.7% | +1.3% | -10.9% |
| ACAD | SELL · 10b5-1 | 2016-12-27 | 2016-12-29 | $30.46 | $299K | +3.3% | +12.7% | +24.0% |
| ACAD | SELL · 10b5-1 | 2016-12-20 | 2016-12-21 | $30.00 | $300K | +16.4% | +13.0% | +27.6% |
| ACAD | SELL · 10b5-1 | 2016-11-10 | 2016-11-14 | $30.07 | $307K | -2.9% | -13.6% | +28.9% |
| ACAD | SELL · 10b5-1 | 2016-07-11 | 2016-07-13 | $35.00 | $560K | +9.0% | -5.8% | -19.3% |
| ACAD | SELL · 10b5-1 | 2016-03-02 | 2016-03-04 | $20.80 | $146K | -7.8% | +42.9% | +75.0% |
| ACAD | SELL · 10b5-1 | 2014-02-26 | 2014-02-28 | $30.28 | $1.3M | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-04-22 | 2013-04-24 | $13.15 | $132K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-04-15 | 2013-04-17 | $12.37 | $619K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-04-11 | 2013-04-12 | $12.42 | $745K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-04-02 | 2013-04-03 | $8.00 | $105K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2012-11-27 | 2012-11-29 | $6.06 | $125K | -33.1% | +0.1% | +0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.